Kryxana 200mg Tablet
By Kryxana
Rx
21 Tablet in a Strip

Composition
Ribociclib(200mg)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
August, 2025

liver
Caution should be taken when using Kryxana 200mg Tablet in patients with severe liver disease. It may be necessary to adjust the dosage of Kryxana 200mg Tablet in such cases. It is important to consult your doctor regarding the use of this medication to ensure safe administration and optimal treatment outcomes.

kidney
Kryxana 200mg Tablet is considered safe for use in patients with kidney disease. Data shows dose adjustment may not be required. Always consult your doctor before use.

alcohol
Consult your doctor when consuming alcohol with Kryxana 200mg Tablet.

driving
While taking Kryxana 200mg Tablet, be careful when driving as it may cause fatigue, dizziness, or vertigo. If you experience these symptoms, use caution when operating vehicles or machinery.

pregnancy
Kryxana 200mg Tablet should be avoided during pregnancy as limited human studies suggest potential harm to the developing baby based on animal studies. Your doctor will assess the risks and benefits before prescribing. Kindly consult your doctor.

breastfeeding
Caution should be taken while breastfeeding if using Kryxana 200mg Tablet, as it is likely unsafe. Limited data shows the drug may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Pyridinylpiperazines |
Therapeutic Class | - |
Action Class | Cyclin-Dependent Kinase Inhibitor |
₹23625
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025